Swiss National Bank’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-53,300
| Closed | -$1.97M | – | 2717 |
|
|
2022
Q3 | $1.97M | Buy |
53,300
+6,600
| +14% | +$244K | ﹤0.01% | 1880 |
|
|
2022
Q2 | $887K | Sell |
46,700
-9,400
| -17% | -$179K | ﹤0.01% | 2433 |
|
|
2022
Q1 | $1.51M | Buy |
56,100
+4,100
| +8% | +$111K | ﹤0.01% | 2195 |
|
|
2021
Q4 | $1.17M | Buy |
52,000
+26,000
| +100% | +$586K | ﹤0.01% | 2383 |
|
|
2021
Q3 | $681K | Buy |
26,000
+900
| +4% | +$23.6K | ﹤0.01% | 2527 |
|
|
2021
Q2 | $803K | Sell |
25,100
-4,600
| -15% | -$147K | ﹤0.01% | 2544 |
|
|
2021
Q1 | $1.05M | Buy |
29,700
+700
| +2% | +$24.7K | ﹤0.01% | 2332 |
|
|
2020
Q4 | $930K | Buy |
29,000
+1,400
| +5% | +$44.9K | ﹤0.01% | 2328 |
|
|
2020
Q3 | $1.04M | Buy |
27,600
+1,000
| +4% | +$37.6K | ﹤0.01% | 2069 |
|
|
2020
Q2 | $1.19M | Buy |
+26,600
| New | +$1.19M | ﹤0.01% | 2006 |
|